OLANZAPINE

OLANZAPINE was reported 69867 times

OLANZAPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN ABNORMAL 551 0.6385
1 ANOSOGNOSIA 477 0.6211
2 DIABETES MELLITUS NON-INSULIN-DEPENDENT 594 0.4082
3 TOTAL LUNG CAPACITY INCREASED 105 0.3860
4 POST-INJECTION DELIRIUM SEDATION SYNDROME 326 0.3778
5 INSPIRATORY CAPACITY DECREASED 102 0.3682
6 CAMPTOCORMIA 77 0.3208
7 DIABETES MELLITUS INSULIN-DEPENDENT 159 0.3161
8 SCHIZOAFFECTIVE DISORDER 536 0.3003
9 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 202 0.2923
10 CENTRAL NERVOUS SYSTEM LUPUS 65 0.2915
11 DELUSION OF GRANDEUR 124 0.2762
12 METABOLIC SYNDROME 414 0.2518
13 DELUSIONAL DISORDER, PERSECUTORY TYPE 101 0.2411
14 NEUROLEPTIC MALIGNANT SYNDROME 2756 0.2321
15 DIABETIC COMA 616 0.2198
16 PLEUROTHOTONUS 198 0.2190
17 METABOLIC DISORDER 1237 0.2128
18 DISTURBANCE IN SOCIAL BEHAVIOUR 476 0.2019
19 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 105 0.2008
20 ORTHOSTATIC HYPERTENSION 113 0.1938
21 PSYCHOTIC SYMPTOM 382 0.1849
22 SCHIZOPHRENIA 2249 0.1849
23 SCHIZOPHRENIA, PARANOID TYPE 65 0.1806
24 OBSESSIVE-COMPULSIVE SYMPTOM 64 0.1734
25 CATATONIA 897 0.1707
26 DISINHIBITION 271 0.1682
27 OCULOGYRIC CRISIS 357 0.1662
28 SINUS RHYTHM 68 0.1560
29 COGWHEEL RIGIDITY 156 0.1486
30 ANTICHOLINERGIC SYNDROME 236 0.1481
31 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 131 0.1472
32 PSYCHIATRIC DECOMPENSATION 262 0.1339
33 NEGATIVISM 97 0.1278
34 PARKINSONISM 1218 0.1248
35 AKATHISIA 1646 0.1205
36 HEPATITIS VIRAL 93 0.1158
37 PRESSURE OF SPEECH 73 0.1123
38 PERSECUTORY DELUSION 279 0.1118
39 HYPOMANIA 408 0.1108
40 KETONURIA 90 0.1106
41 GLYCOSURIA 149 0.1102
42 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 121 0.1088
43 EMOTIONAL POVERTY 190 0.1083
44 ANTIPSYCHOTIC DRUG LEVEL INCREASED 299 0.1061
45 RESTING TREMOR 68 0.1053
46 ENDOCRINE DISORDER 133 0.1037
47 HYPERPROLACTINAEMIA 664 0.1023
48 BLOOD PROLACTIN INCREASED 468 0.0992
49 SEDATION 2597 0.0991
50 SEDATION COMPLICATION 250 0.0979
51 POLYDIPSIA 378 0.0955
52 SUSPICIOUSNESS 67 0.0953
53 HALLUCINATION, AUDITORY 1496 0.0941
54 BLUNTED AFFECT 69 0.0935
55 OROMANDIBULAR DYSTONIA 68 0.0933
56 MUTISM 131 0.0902
57 PSYCHOTIC DISORDER 2660 0.0900
58 OBESITY 1417 0.0889
59 DELUSIONAL DISORDER, UNSPECIFIED TYPE 66 0.0882
60 BLOOD CHOLESTEROL ABNORMAL 396 0.0856
61 SOPOR 1119 0.0844
62 INTESTINAL PSEUDO-OBSTRUCTION 73 0.0830
63 DELUSION 1262 0.0812
64 REDUCED FACIAL EXPRESSION 82 0.0808
65 PSYCHOMOTOR RETARDATION 226 0.0803
66 SALIVARY HYPERSECRETION 774 0.0773
67 DIABETIC NEUROPATHY 380 0.0767
68 DYSLIPIDAEMIA 385 0.0757
69 MYOCARDITIS 866 0.0755
70 EOSINOPHIL COUNT DECREASED 179 0.0751
71 BUTTERFLY RASH 75 0.0740
72 EXTRAPYRAMIDAL DISORDER 1786 0.0719
73 ACCIDENTAL DEATH 133 0.0715
74 MANIA 1170 0.0710
75 BIPOLAR I DISORDER 156 0.0710
76 DIABETES MELLITUS 5418 0.0710
77 TYPE 1 DIABETES MELLITUS 420 0.0697
78 MUSCLE RIGIDITY 832 0.0695
79 SEXUAL DYSFUNCTION 811 0.0691
80 ACUTE PSYCHOSIS 171 0.0691
81 MEGACOLON 108 0.0687
82 DYSTONIA 1329 0.0684
83 BLOOD TRIGLYCERIDES INCREASED 1187 0.0671
84 PRIAPISM 231 0.0669
85 OBSESSIVE THOUGHTS 119 0.0660
86 HYPERAMMONAEMIC ENCEPHALOPATHY 114 0.0655
87 MIOSIS 517 0.0644
88 HYPOTONIA NEONATAL 99 0.0633
89 OBSESSIVE-COMPULSIVE DISORDER 508 0.0632
90 PRESCRIBED OVERDOSE 1224 0.0632
91 INTENTIONAL SELF-INJURY 1253 0.0620
92 PERSONALITY CHANGE 573 0.0616
93 FEEDING DISORDER NEONATAL 63 0.0602
94 ILLUSION 98 0.0592
95 SOCIAL AVOIDANT BEHAVIOUR 341 0.0589
96 JAUNDICE CHOLESTATIC 207 0.0585
97 TYPE 2 DIABETES MELLITUS 1950 0.0579
98 ELECTROCARDIOGRAM QT PROLONGED 2079 0.0577
99 TORTICOLLIS 122 0.0575
100 POSTURE ABNORMAL 186 0.0571
101 BODY MASS INDEX INCREASED 76 0.0563
102 HALLUCINATIONS, MIXED 234 0.0556
103 HYPOTHERMIA 562 0.0555
104 APRAXIA 81 0.0546
105 TROPONIN T INCREASED 69 0.0544
106 SUICIDE ATTEMPT 3256 0.0536
107 HYPERPHAGIA 214 0.0536
108 BIPOLAR DISORDER 583 0.0536
109 AUTONOMIC NERVOUS SYSTEM IMBALANCE 155 0.0530
110 FLAT AFFECT 122 0.0527
111 FEELING GUILTY 69 0.0523
112 PANCREATITIS NECROTISING 120 0.0522
113 ENCEPHALITIS AUTOIMMUNE 68 0.0517
114 GESTATIONAL DIABETES 245 0.0514
115 DIABETIC KETOACIDOSIS 1215 0.0505
116 DIABETIC COMPLICATION 128 0.0502
117 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 112 0.0500
118 INSULIN RESISTANCE 104 0.0499
119 STUPOR 159 0.0494
120 PERSONALITY DISORDER 128 0.0488
121 COMA SCALE ABNORMAL 140 0.0483
122 IMPULSE-CONTROL DISORDER 98 0.0476
123 DEREALISATION 102 0.0474
124 STARING 114 0.0471
125 BEZOAR 65 0.0471
126 PARANOIA 797 0.0462
127 HYPERSEXUALITY 83 0.0454
128 SEROTONIN SYNDROME 865 0.0450
129 HYPERLIPIDAEMIA 533 0.0446
130 BRADYPHRENIA 289 0.0442
131 GRANULOCYTOPENIA 251 0.0440
132 HYPERTHERMIA 335 0.0438
133 HYPERGLYCAEMIA 1592 0.0436
134 SELF INJURIOUS BEHAVIOUR 133 0.0435
135 DEPRESSIVE SYMPTOM 152 0.0431
136 INCREASED APPETITE 823 0.0430
137 INAPPROPRIATE AFFECT 68 0.0429
138 HYPERTRIGLYCERIDAEMIA 251 0.0428
139 RESPIRATORY ALKALOSIS 69 0.0424
140 LOGORRHOEA 147 0.0417
141 GAZE PALSY 71 0.0416
142 DROOLING 286 0.0414
143 PANCREATITIS CHRONIC 98 0.0414
144 SUDDEN CARDIAC DEATH 141 0.0413
145 IMPULSIVE BEHAVIOUR 154 0.0410
146 GLUCOSE TOLERANCE IMPAIRED 242 0.0409
147 MAJOR DEPRESSION 299 0.0409
148 DELIRIUM 1410 0.0406
149 TARDIVE DYSKINESIA 1143 0.0405
150 BRADYKINESIA 239 0.0404
151 SINUS TACHYCARDIA 570 0.0401
152 NEUTROPHIL COUNT INCREASED 410 0.0400
153 APLASTIC ANAEMIA 209 0.0400
154 ALCOHOL ABUSE 107 0.0400
155 BLOOD CREATINE PHOSPHOKINASE INCREASED 1139 0.0395
156 THERAPEUTIC PRODUCT EFFECT VARIABLE 153 0.0394
157 INTENTIONAL OVERDOSE 2515 0.0392
158 AKINESIA 81 0.0391
159 PSYCHOMOTOR SKILLS IMPAIRED 102 0.0389
160 LONG QT SYNDROME 93 0.0387
161 HYPERREFLEXIA 135 0.0387
162 POISONING DELIBERATE 367 0.0387
163 THERAPEUTIC AGENT TOXICITY 129 0.0386
164 GALACTORRHOEA 247 0.0384
165 WRONG PATIENT RECEIVED PRODUCT 112 0.0382
166 DRUG LEVEL INCREASED 633 0.0382
167 AGGRESSION 1913 0.0382
168 AGITATION 2806 0.0382
169 HOSTILITY 97 0.0381
170 DYSKINESIA 1544 0.0380
171 PSYCHIATRIC SYMPTOM 279 0.0378
172 DEPRESSED LEVEL OF CONSCIOUSNESS 1482 0.0374
173 RESPIRATORY DEPRESSION 457 0.0372
174 PNEUMONIA ASPIRATION 931 0.0372
175 HYPERAMMONAEMIA 186 0.0372
176 SELF-INJURIOUS IDEATION 156 0.0371
177 MEAN CELL HAEMOGLOBIN DECREASED 68 0.0371
178 ELECTROENCEPHALOGRAM ABNORMAL 117 0.0370
179 ILEUS PARALYTIC 165 0.0369
180 HYPERNATRAEMIA 184 0.0369
181 MULTIPLE DRUG OVERDOSE INTENTIONAL 118 0.0367
182 AFFECTIVE DISORDER 287 0.0365
183 POLYURIA 298 0.0364
184 MENTAL IMPAIRMENT 878 0.0362
185 IMPAIRED SELF-CARE 75 0.0362
186 PANCREATITIS 1911 0.0361
187 LUPUS NEPHRITIS 67 0.0358
188 TROPONIN INCREASED 272 0.0357
189 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 367 0.0357
190 COMA 1702 0.0357
191 FAECALOMA 194 0.0354
192 RESTLESSNESS 1295 0.0353
193 PARADOXICAL DRUG REACTION 130 0.0353
194 SUBSTANCE USE DISORDER 112 0.0351
195 DIABETIC NEPHROPATHY 77 0.0350
196 ELECTROCARDIOGRAM T WAVE INVERSION 77 0.0348
197 COMMUNICATION DISORDER 133 0.0347
198 DISORGANISED SPEECH 64 0.0347
199 EUPHORIC MOOD 351 0.0342
200 OVERWEIGHT 183 0.0340
201 HIGH DENSITY LIPOPROTEIN DECREASED 113 0.0339
202 INTENTIONAL MISUSE 64 0.0335
203 MULTIPLE DRUG OVERDOSE 166 0.0334
204 APATHY 483 0.0331
205 BEHAVIOUR DISORDER 178 0.0329
206 RHINITIS ALLERGIC 146 0.0328
207 PSYCHOMOTOR HYPERACTIVITY 542 0.0326
208 BLOOD SODIUM INCREASED 88 0.0326
209 PHYSICAL ASSAULT 68 0.0325
210 HOMICIDAL IDEATION 131 0.0323
211 CLONUS 87 0.0318
212 SLOW SPEECH 77 0.0317
213 VENTRICULAR ARRHYTHMIA 115 0.0314
214 FOOD CRAVING 164 0.0311
215 BRADYPNOEA 84 0.0311
216 REFUSAL OF TREATMENT BY PATIENT 202 0.0309
217 HYPERTONIA 177 0.0309
218 WEIGHT INCREASED 6911 0.0308
219 BREAST ENLARGEMENT 101 0.0308
220 BUNDLE BRANCH BLOCK RIGHT 141 0.0307
221 CEREBRAL ATROPHY 121 0.0303
222 BLOOD CHLORIDE DECREASED 78 0.0302
223 RHABDOMYOLYSIS 1259 0.0302
224 SUBSTANCE ABUSE 244 0.0299
225 POISONING 376 0.0299
226 COMPARTMENT SYNDROME 78 0.0299
227 COMPLETED SUICIDE 2480 0.0297
228 SUDDEN DEATH 313 0.0296
229 ENURESIS 118 0.0292
230 ALTERED STATE OF CONSCIOUSNESS 631 0.0291
231 SOMNAMBULISM 191 0.0291
232 SUICIDAL BEHAVIOUR 121 0.0291
233 HALLUCINATION, VISUAL 614 0.0291
234 EMBOLISM VENOUS 88 0.0290
235 ABNORMAL BEHAVIOUR 1144 0.0288
236 DYSARTHRIA 1076 0.0286
237 TORSADE DE POINTES 223 0.0284
238 THINKING ABNORMAL 529 0.0284
239 BLOOD CHOLESTEROL INCREASED 1315 0.0282
240 GAMBLING DISORDER 76 0.0281
241 KETOACIDOSIS 210 0.0280
242 BRAIN INJURY 280 0.0279
243 DIABETES INSIPIDUS 67 0.0278
244 DIABETIC RETINOPATHY 94 0.0276
245 TOXIC ENCEPHALOPATHY 140 0.0276
246 COLITIS ISCHAEMIC 185 0.0274
247 TREATMENT NONCOMPLIANCE 1499 0.0274
248 SUICIDAL IDEATION 2504 0.0273
249 HYPERCHOLESTEROLAEMIA 264 0.0273
250 URINARY HESITATION 65 0.0272
251 TENSION 165 0.0271
252 DRUG INTERACTION 4298 0.0271
253 DRUG LEVEL ABOVE THERAPEUTIC 124 0.0270
254 DRUG ABUSE 2251 0.0270
255 AGRANULOCYTOSIS 501 0.0269
256 TACHYPHRENIA 93 0.0268
257 DRUG TOXICITY 356 0.0261
258 TOXICITY TO VARIOUS AGENTS 4386 0.0260
259 ASPIRATION 284 0.0259
260 POTENTIATING DRUG INTERACTION 87 0.0259
261 TACHYCARDIA 2286 0.0257
262 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 67 0.0256
263 ELECTROCARDIOGRAM ABNORMAL 200 0.0255
264 SARCOIDOSIS 121 0.0254
265 LYMPHOCYTE COUNT INCREASED 82 0.0251
266 MONOCYTE COUNT INCREASED 91 0.0250
267 MYOCLONUS 297 0.0249
268 HYPOVENTILATION 81 0.0248
269 EOSINOPHIL COUNT INCREASED 206 0.0247
270 HYPONATRAEMIA 1390 0.0247
271 LEUKOPENIA 1233 0.0246
272 DIABETES MELLITUS INADEQUATE CONTROL 435 0.0245
273 GASTROINTESTINAL NECROSIS 71 0.0243
274 LEUKOCYTOSIS 438 0.0242
275 DRUG USE DISORDER 203 0.0241
276 SNORING 91 0.0240
277 ATRIOVENTRICULAR BLOCK FIRST DEGREE 104 0.0240
278 GENERALISED TONIC-CLONIC SEIZURE 396 0.0239
279 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 121 0.0236
280 NEGATIVE THOUGHTS 69 0.0235
281 ORTHOSTATIC HYPOTENSION 406 0.0233
282 HYPERCAPNIA 70 0.0232
283 UNRESPONSIVE TO STIMULI 598 0.0231
284 FEBRILE NEUTROPENIA 1536 0.0231
285 SUSPECTED SUICIDE 107 0.0228
286 HEPATIC STEATOSIS 422 0.0226
287 HYPERVENTILATION 130 0.0224
288 MENTAL DISORDER 967 0.0222
289 RED CELL DISTRIBUTION WIDTH INCREASED 92 0.0221
290 EYE MOVEMENT DISORDER 151 0.0220
291 MENTAL STATUS CHANGES 610 0.0219
292 GRAND MAL CONVULSION 201 0.0217
293 SINUS BRADYCARDIA 210 0.0217
294 CARDIAC MURMUR 187 0.0216
295 CONGESTIVE CARDIOMYOPATHY 90 0.0216
296 NASAL POLYPS 106 0.0215
297 MYDRIASIS 274 0.0213
298 TIC 116 0.0212
299 DISORIENTATION 840 0.0212
300 SCREAMING 135 0.0212
301 VENTRICULAR HYPOKINESIA 67 0.0208
302 URINARY RETENTION 696 0.0208
303 PETIT MAL EPILEPSY 106 0.0207
304 NEUTROPHIL COUNT DECREASED 846 0.0207
305 HYPOTONIA 207 0.0207
306 HALLUCINATION 1554 0.0206
307 RESPIRATORY ACIDOSIS 81 0.0206
308 ALCOHOL USE 76 0.0206
309 MUSCLE CONTRACTIONS INVOLUNTARY 72 0.0205
310 DYSPHORIA 103 0.0203
311 SOMNOLENCE 4029 0.0200
312 CARDIO-RESPIRATORY ARREST 832 0.0199
313 ASPHYXIA 162 0.0198
314 BLEPHAROSPASM 124 0.0197
315 CARDIOMYOPATHY 290 0.0196
316 POST-TRAUMATIC STRESS DISORDER 131 0.0195
317 ATAXIA 231 0.0194
318 AFFECT LABILITY 187 0.0194
319 LEFT VENTRICULAR DYSFUNCTION 130 0.0194
320 EOSINOPHILIA 340 0.0194
321 COGNITIVE DISORDER 898 0.0192
322 TACHYPNOEA 260 0.0191
323 HAEMATOCRIT DECREASED 379 0.0191
324 PROTEIN URINE PRESENT 95 0.0190
325 TRISMUS 98 0.0190
326 SUPRAVENTRICULAR EXTRASYSTOLES 64 0.0189
327 NEONATAL RESPIRATORY DISTRESS SYNDROME 67 0.0189
328 PANCREATITIS ACUTE 424 0.0188
329 ABNORMAL WEIGHT GAIN 233 0.0188
330 GAMMA-GLUTAMYLTRANSFERASE INCREASED 418 0.0188
331 INCOHERENT 122 0.0188
332 HEPATOCELLULAR INJURY 267 0.0188
333 INCONTINENCE 198 0.0187
334 HYPERSOMNIA 533 0.0186
335 PANIC DISORDER 72 0.0186
336 BRONCHIECTASIS 124 0.0184
337 BRUXISM 99 0.0183
338 RESPIRATORY ARREST 505 0.0183
339 CONFUSIONAL STATE 2933 0.0181
340 C-REACTIVE PROTEIN INCREASED 658 0.0181
341 SPEECH DISORDER 935 0.0178
342 CONGENITAL ANOMALY 138 0.0178
343 ACUTE PULMONARY OEDEMA 100 0.0178
344 HYPOGLYCAEMIA 864 0.0178
345 WHITE BLOOD CELL COUNT INCREASED 683 0.0178
346 DRUG LEVEL BELOW THERAPEUTIC 98 0.0177
347 FAECAL INCONTINENCE 85 0.0177
348 DYSPHEMIA 77 0.0175
349 DISTURBANCE IN ATTENTION 943 0.0175
350 MUSCLE TWITCHING 403 0.0175
351 DISSOCIATION 132 0.0172
352 URINARY INCONTINENCE 508 0.0171
353 PRE-ECLAMPSIA 81 0.0170
354 LYMPHOCYTE COUNT DECREASED 300 0.0170
355 SMALL FOR DATES BABY 84 0.0169
356 LEFT VENTRICULAR HYPERTROPHY 71 0.0166
357 EATING DISORDER 350 0.0164
358 PULSE ABSENT 78 0.0164
359 ERECTILE DYSFUNCTION 421 0.0164
360 MYOCARDIAL ISCHAEMIA 186 0.0163
361 BRAIN OEDEMA 206 0.0163
362 BUNDLE BRANCH BLOCK LEFT 69 0.0163
363 CHOLELITHIASIS 532 0.0162
364 OVERDOSE 3490 0.0162
365 NEUTROPENIA 2194 0.0161
366 HYPOVOLAEMIA 94 0.0160
367 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 109 0.0160
368 ELECTROLYTE IMBALANCE 186 0.0160
369 MOTOR DYSFUNCTION 163 0.0160
370 TREMOR 2651 0.0160
371 DRUG EXPOSURE DURING PREGNANCY 543 0.0159
372 BLOOD LACTIC ACID INCREASED 84 0.0159
373 APNOEA 124 0.0159
374 ALANINE AMINOTRANSFERASE INCREASED 977 0.0159
375 SELF-MEDICATION 65 0.0158
376 ARTERIOSCLEROSIS CORONARY ARTERY 104 0.0157
377 ALCOHOLISM 67 0.0156
378 GYNAECOMASTIA 482 0.0156
379 VENTRICULAR FIBRILLATION 173 0.0156
380 ACIDOSIS 119 0.0156
381 ASPARTATE AMINOTRANSFERASE INCREASED 827 0.0156
382 NEUTROPHILIA 87 0.0153
383 HUNGER 213 0.0153
384 PULMONARY EMBOLISM 1451 0.0153
385 DRUG RESISTANCE 390 0.0152
386 BLOOD ALKALINE PHOSPHATASE INCREASED 377 0.0152
387 AMENORRHOEA 266 0.0152
388 IRRITABILITY 912 0.0152
389 VENTRICULAR TACHYCARDIA 248 0.0150
390 RESTLESS LEGS SYNDROME 273 0.0150
391 THERMAL BURN 106 0.0149
392 HEPATIC CYTOLYSIS 190 0.0149
393 LOW DENSITY LIPOPROTEIN INCREASED 115 0.0148
394 FLANK PAIN 139 0.0148
395 NEPHROPATHY 138 0.0148
396 MALNUTRITION 165 0.0147
397 EPILEPSY 450 0.0147
398 WITHDRAWAL SYNDROME 615 0.0146
399 HYPOKINESIA 212 0.0146
400 NYSTAGMUS 77 0.0145
401 AMMONIA INCREASED 74 0.0145
402 VASCULITIS 167 0.0143
403 THIRST 256 0.0143
404 ENCEPHALOPATHY 351 0.0143
405 SLEEP APNOEA SYNDROME 272 0.0142
406 HYPERTRANSAMINASAEMIA 99 0.0142
407 HAEMODYNAMIC INSTABILITY 108 0.0142
408 DRUG SCREEN POSITIVE 112 0.0142
409 THERAPY PARTIAL RESPONDER 221 0.0142
410 INJURY 990 0.0141
411 HYPOALBUMINAEMIA 109 0.0140
412 ILEUS 173 0.0139
413 BLOOD SODIUM DECREASED 262 0.0139
414 SLUGGISHNESS 141 0.0138
415 COORDINATION ABNORMAL 192 0.0138
416 CONVULSION 786 0.0137
417 HEPATOTOXICITY 305 0.0137
418 PULMONARY CONGESTION 180 0.0136
419 BLOOD ALBUMIN DECREASED 108 0.0136
420 HYPOKALAEMIA 625 0.0135
421 BLOOD BILIRUBIN INCREASED 365 0.0135
422 CARDIOMEGALY 166 0.0135
423 CARDIAC ARREST 1112 0.0135
424 ANGER 455 0.0134
425 CIRCULATORY COLLAPSE 229 0.0134
426 DECUBITUS ULCER 109 0.0134
427 GENERAL PHYSICAL HEALTH DETERIORATION 1545 0.0133
428 WHITE BLOOD CELL COUNT DECREASED 1440 0.0133
429 BLOOD LACTATE DEHYDROGENASE INCREASED 210 0.0132
430 FAILURE TO THRIVE 68 0.0131
431 DRUG ABUSER 80 0.0130
432 PANIC ATTACK 470 0.0129
433 EXTRASYSTOLES 90 0.0129
434 HYPOPHAGIA 329 0.0129
435 LETHARGY 730 0.0127
436 LIVER FUNCTION TEST ABNORMAL 369 0.0127
437 HYPOXIA 446 0.0127
438 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 323 0.0125
439 GENERAL PHYSICAL CONDITION ABNORMAL 85 0.0125
440 LOSS OF CONSCIOUSNESS 1597 0.0125
441 METABOLIC ACIDOSIS 398 0.0124
442 LEUKAEMIA 117 0.0124
443 MOVEMENT DISORDER 397 0.0124
444 DEPRESSED MOOD 653 0.0123
445 BODY TEMPERATURE INCREASED 252 0.0123
446 BRADYCARDIA 653 0.0123
447 ARRHYTHMIA 582 0.0123
448 LIPASE INCREASED 94 0.0123
449 ANXIETY 3483 0.0122
450 TRANSAMINASES INCREASED 272 0.0122
451 STATUS EPILEPTICUS 138 0.0122
452 TRICUSPID VALVE INCOMPETENCE 96 0.0121
453 BLOOD GLUCOSE ABNORMAL 223 0.0121
454 ATRIAL SEPTAL DEFECT 101 0.0120
455 ACUTE RESPIRATORY FAILURE 232 0.0120
456 GENERALISED OEDEMA 149 0.0120
457 INTRACRANIAL PRESSURE INCREASED 67 0.0120
458 HEPATITIS C 145 0.0120
459 HICCUPS 98 0.0119
460 MITRAL VALVE INCOMPETENCE 135 0.0119
461 THERAPY NON-RESPONDER 533 0.0118
462 HYPERTENSION 2511 0.0118
463 SEIZURE 1369 0.0118
464 CYANOSIS 186 0.0118
465 FEAR 318 0.0118
466 INTESTINAL ISCHAEMIA 65 0.0118
467 DEPRESSION 2677 0.0118
468 HEPATOMEGALY 115 0.0117
469 DECREASED INTEREST 69 0.0117
470 DRUG LEVEL DECREASED 119 0.0117
471 RESPIRATORY DISTRESS 321 0.0116
472 AMNESIA 748 0.0115
473 RED BLOOD CELL SEDIMENTATION RATE INCREASED 127 0.0115
474 PLATELET COUNT INCREASED 149 0.0114
475 RESPIRATORY RATE INCREASED 100 0.0113
476 DYSPHAGIA 1065 0.0112
477 PANCYTOPENIA 626 0.0112
478 NEUROLOGICAL SYMPTOM 64 0.0112
479 ACUTE RESPIRATORY DISTRESS SYNDROME 198 0.0112
480 PERICARDITIS 188 0.0112
481 DRUG-INDUCED LIVER INJURY 351 0.0112
482 DEMENTIA 312 0.0112
483 ACUTE HEPATIC FAILURE 152 0.0111
484 MUCOSAL INFLAMMATION 291 0.0111
485 APHASIA 334 0.0110
486 IRON DEFICIENCY ANAEMIA 102 0.0110
487 HYPOTENSION 2216 0.0110
488 HYPOCALCAEMIA 209 0.0110
489 FOETAL EXPOSURE DURING PREGNANCY 893 0.0110
490 MEDICATION ERROR 610 0.0110
491 CYTOKINE RELEASE SYNDROME 219 0.0109
492 INSOMNIA 2906 0.0109
493 VENTRICULAR EXTRASYSTOLES 113 0.0109
494 RESPIRATION ABNORMAL 74 0.0107
495 CARDIOGENIC SHOCK 153 0.0107
496 ACCIDENTAL OVERDOSE 388 0.0106
497 RED BLOOD CELL COUNT DECREASED 298 0.0104
498 FACIAL PARALYSIS 88 0.0103
499 POOR QUALITY SLEEP 222 0.0103
500 DEEP VEIN THROMBOSIS 669 0.0103
501 EJECTION FRACTION DECREASED 160 0.0103
502 RENAL FAILURE CHRONIC 79 0.0103
503 REBOUND EFFECT 116 0.0103
504 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 727 0.0102
505 CARDIAC FAILURE ACUTE 68 0.0102
506 HEPATITIS ACUTE 66 0.0101
507 SUPRAVENTRICULAR TACHYCARDIA 97 0.0101
508 THROMBOCYTOPENIA 1132 0.0101
509 NEUROTOXICITY 177 0.0101
510 FULL BLOOD COUNT ABNORMAL 106 0.0100
511 HEPATIC FUNCTION ABNORMAL 374 0.0100
512 CONDITION AGGRAVATED 3029 0.0100
513 ATELECTASIS 96 0.0099
514 FACIAL PAIN 88 0.0098
515 RENAL FAILURE ACUTE 418 0.0098
516 EMOTIONAL DISORDER 302 0.0098
517 CAESAREAN SECTION 113 0.0097
518 HYPERHIDROSIS 1249 0.0097
519 HEAD INJURY 306 0.0097
520 INTENTIONAL DRUG MISUSE 202 0.0097
521 MATERNAL DRUGS AFFECTING FOETUS 74 0.0096
522 ATRIAL FLUTTER 77 0.0096
523 MOOD ALTERED 263 0.0096
524 CHOLESTASIS 185 0.0096
525 SLEEP DISORDER 673 0.0095
526 RESPIRATORY FAILURE 695 0.0095
527 PERICARDIAL EFFUSION 220 0.0095
528 SUBARACHNOID HAEMORRHAGE 96 0.0094
529 HEPATIC ENZYME INCREASED 639 0.0094
530 HYPOTHYROIDISM 299 0.0094
531 BLOOD DISORDER 75 0.0094
532 SHOCK 215 0.0093
533 PLATELET COUNT DECREASED 990 0.0093
534 DECREASED ACTIVITY 100 0.0093
535 DYSURIA 341 0.0093
536 TONGUE DISORDER 67 0.0093
537 BLOOD UREA INCREASED 155 0.0092
538 SYNCOPE 926 0.0092
539 CONSTIPATION 2014 0.0092
540 SPINAL OSTEOARTHRITIS 81 0.0092
541 CEREBRAL DISORDER 68 0.0092
542 EXPOSURE DURING PREGNANCY 571 0.0092
543 DRUG WITHDRAWAL SYNDROME NEONATAL 135 0.0091
544 BLOOD CREATININE INCREASED 593 0.0091
545 HYPOPHOSPHATAEMIA 67 0.0091
546 LACERATION 85 0.0090
547 DEHYDRATION 1205 0.0090
548 ANHEDONIA 237 0.0090
549 PULMONARY OEDEMA 403 0.0090
550 IMPAIRED GASTRIC EMPTYING 120 0.0088
551 INSURANCE ISSUE 134 0.0088
552 MOOD SWINGS 279 0.0087
553 OEDEMA PERIPHERAL 1066 0.0087
554 CARDIOTOXICITY 78 0.0087
555 HEPATIC ENCEPHALOPATHY 81 0.0087
556 NIGHTMARE 300 0.0087
557 BODY TEMPERATURE DECREASED 85 0.0086
558 VITAMIN D DEFICIENCY 84 0.0086
559 CHOKING 168 0.0086
560 HEPATITIS 220 0.0086
561 HYPERCALCAEMIA 106 0.0086
562 GLYCOSYLATED HAEMOGLOBIN INCREASED 216 0.0085
563 HAEMOGLOBIN DECREASED 876 0.0085
564 ARTERIOSCLEROSIS 80 0.0085
565 ACUTE KIDNEY INJURY 1298 0.0085
566 INTESTINAL OBSTRUCTION 316 0.0084
567 VISION BLURRED 1148 0.0084
568 SEPTIC SHOCK 363 0.0083
569 TOXIC SKIN ERUPTION 84 0.0083
570 ANAL INCONTINENCE 75 0.0083
571 INITIAL INSOMNIA 85 0.0083
572 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 432 0.0083
573 LYMPHOPENIA 117 0.0083
574 FALL 2747 0.0082
575 MEMORY IMPAIRMENT 1128 0.0082
576 BLOOD GLUCOSE INCREASED 1546 0.0082
577 DIPLOPIA 213 0.0082
578 INTENTIONAL PRODUCT MISUSE 718 0.0082
579 DRY MOUTH 665 0.0082
580 NERVE INJURY 91 0.0082
581 BLOOD CALCIUM DECREASED 92 0.0082
582 BALANCE DISORDER 706 0.0082
583 FACE OEDEMA 136 0.0081
584 OESOPHAGITIS 88 0.0080
585 STEVENS-JOHNSON SYNDROME 179 0.0080
586 POLLAKIURIA 335 0.0080
587 ANURIA 69 0.0080
588 MUSCULOSKELETAL STIFFNESS 702 0.0080
589 BLOOD MAGNESIUM DECREASED 69 0.0080
590 BREAST PAIN 85 0.0080
591 MENSTRUAL DISORDER 66 0.0080
592 COVID-19 PNEUMONIA 94 0.0080
593 WEIGHT FLUCTUATION 83 0.0079
594 FRUSTRATION TOLERANCE DECREASED 64 0.0079
595 GASTROENTERITIS 115 0.0079
596 RASH MACULO-PAPULAR 175 0.0079
597 HAEMATEMESIS 199 0.0078
598 UROSEPSIS 72 0.0078
599 SEPSIS 862 0.0077
600 NERVOUS SYSTEM DISORDER 241 0.0077
601 ANOREXIA 99 0.0077
602 CHOLECYSTITIS 91 0.0076
603 BLOOD URINE PRESENT 145 0.0076
604 HEPATIC FAILURE 230 0.0076
605 CHEST PAIN 1411 0.0076
606 OXYGEN SATURATION DECREASED 428 0.0076
607 ACUTE CORONARY SYNDROME 63 0.0076
608 CELLULITIS 383 0.0076
609 BACTERAEMIA 90 0.0076
610 PYREXIA 2607 0.0075
611 PALLOR 205 0.0075
612 MUSCLE TIGHTNESS 122 0.0075
613 DENTAL CARIES 83 0.0075
614 CEREBRAL INFARCTION 183 0.0075
615 PRODUCT PRESCRIBING ERROR 178 0.0075
616 MULTIPLE ORGAN DYSFUNCTION SYNDROME 211 0.0074
617 GASTRITIS 195 0.0074
618 HEART RATE INCREASED 734 0.0074
619 ECONOMIC PROBLEM 112 0.0074
620 HAEMOLYTIC ANAEMIA 66 0.0074
621 GAIT DISTURBANCE 1406 0.0073
622 LIVER DISORDER 324 0.0073
623 MYOPATHY 63 0.0073
624 LIVER INJURY 179 0.0073
625 DISABILITY 144 0.0073
626 DRUG ERUPTION 129 0.0073
627 OEDEMA 394 0.0073
628 SPLENOMEGALY 85 0.0072
629 PNEUMONIA 2346 0.0072
630 TRANSIENT ISCHAEMIC ATTACK 243 0.0072
631 DRUG WITHDRAWAL SYNDROME 630 0.0072
632 QUALITY OF LIFE DECREASED 96 0.0071
633 VOMITING 3357 0.0071
634 OBSTRUCTIVE AIRWAYS DISORDER 79 0.0071
635 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 386 0.0070
636 RENAL TUBULAR NECROSIS 69 0.0070
637 PREMATURE BABY 211 0.0070
638 OFF LABEL USE 6127 0.0070
639 RENAL FAILURE 928 0.0070
640 TREATMENT FAILURE 578 0.0070
641 PRODUCT ADMINISTRATION ERROR 141 0.0070
642 DISEASE RECURRENCE 330 0.0069
643 ACTIVITIES OF DAILY LIVING IMPAIRED 137 0.0069
644 PARALYSIS 99 0.0069
645 TOXIC EPIDERMAL NECROLYSIS 105 0.0069
646 GASTROOESOPHAGEAL REFLUX DISEASE 555 0.0069
647 BRAIN FOG 108 0.0069
648 CRYING 250 0.0069
649 TRANSFUSION 72 0.0069
650 HYPERKALAEMIA 240 0.0068
651 BLOOD POTASSIUM INCREASED 111 0.0068
652 IMPAIRED QUALITY OF LIFE 98 0.0068
653 HOSPITALISATION 1047 0.0068
654 SKIN LACERATION 74 0.0068
655 HIATUS HERNIA 88 0.0068
656 NEUROPATHY PERIPHERAL 646 0.0068
657 PHARYNGITIS 84 0.0068
658 INTESTINAL PERFORATION 76 0.0068
659 LIVER FUNCTION TEST INCREASED 144 0.0067
660 DIZZINESS POSTURAL 65 0.0067
661 ADVERSE DRUG REACTION 601 0.0067
662 ISCHAEMIC STROKE 119 0.0067
663 NO THERAPEUTIC RESPONSE 81 0.0066
664 PRODUCT USE IN UNAPPROVED INDICATION 1646 0.0066
665 ANAEMIA 1264 0.0066
666 RIB FRACTURE 135 0.0066
667 DECREASED APPETITE 1516 0.0065
668 BLOOD POTASSIUM DECREASED 196 0.0065
669 WOUND 182 0.0065
670 NERVOUSNESS 340 0.0065
671 WEIGHT DECREASED 1814 0.0065
672 BEDRIDDEN 85 0.0065
673 LACTIC ACIDOSIS 209 0.0064
674 EMPHYSEMA 65 0.0064
675 TINNITUS 296 0.0064
676 SARS-COV-2 TEST POSITIVE 85 0.0064
677 CLOSTRIDIUM DIFFICILE COLITIS 68 0.0064
678 HYPOMAGNESAEMIA 89 0.0064
679 JAUNDICE 172 0.0064
680 HEPATIC CIRRHOSIS 120 0.0064
681 ACUTE MYOCARDIAL INFARCTION 188 0.0064
682 IMPAIRED WORK ABILITY 134 0.0063
683 SCRATCH 66 0.0063
684 HEAD DISCOMFORT 110 0.0062
685 CORONARY ARTERY DISEASE 188 0.0062
686 PLEURAL EFFUSION 375 0.0062
687 FEELING ABNORMAL 1468 0.0061
688 BLOOD PRESSURE SYSTOLIC INCREASED 119 0.0061
689 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292 0.0061
690 MOUTH ULCERATION 128 0.0061
691 COAGULOPATHY 101 0.0061
692 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
693 FEELING JITTERY 115 0.0060
694 PHOTOSENSITIVITY REACTION 99 0.0060
695 PRESYNCOPE 145 0.0060
696 CARDIAC FAILURE 478 0.0059
697 RENAL DISORDER 277 0.0059
698 DYSSTASIA 173 0.0059
699 CARDIAC DISORDER 554 0.0059
700 RENAL IMPAIRMENT 497 0.0059
701 ROAD TRAFFIC ACCIDENT 247 0.0059
702 COLD SWEAT 104 0.0059
703 BREAST CANCER METASTATIC 63 0.0059
704 FEELING COLD 163 0.0058
705 STAPHYLOCOCCAL INFECTION 193 0.0058
706 MULTI-ORGAN FAILURE 101 0.0058
707 SMALL INTESTINAL OBSTRUCTION 71 0.0058
708 ASTHENIA 2163 0.0057
709 DRUG INEFFECTIVE 7555 0.0057
710 CONJUNCTIVITIS 106 0.0057
711 BLOOD PRESSURE DECREASED 379 0.0057
712 PERITONITIS 118 0.0057
713 ABNORMAL DREAMS 157 0.0057
714 DRUG INTOLERANCE 549 0.0057
715 POLYNEUROPATHY 68 0.0057
716 PNEUMONITIS 154 0.0057
717 BLINDNESS 230 0.0056
718 DIALYSIS 80 0.0056
719 PALPITATIONS 658 0.0056
720 URINARY TRACT INFECTION 954 0.0056
721 THERAPEUTIC RESPONSE DECREASED 339 0.0056
722 BLOOD PRESSURE FLUCTUATION 134 0.0056
723 ASCITES 164 0.0056
724 TASTE DISORDER 113 0.0056
725 RECTAL HAEMORRHAGE 238 0.0055
726 LOWER RESPIRATORY TRACT INFECTION 251 0.0055
727 PHOTOPHOBIA 103 0.0055
728 GLOMERULAR FILTRATION RATE DECREASED 67 0.0054
729 HEART RATE IRREGULAR 123 0.0054
730 RETCHING 116 0.0054
731 ADRENAL INSUFFICIENCY 66 0.0054
732 PLASMA CELL MYELOMA 212 0.0054
733 SWOLLEN TONGUE 169 0.0054
734 MATERNAL EXPOSURE DURING PREGNANCY 481 0.0054
735 VISUAL ACUITY REDUCED 179 0.0054
736 ABDOMINAL PAIN 1253 0.0054
737 RESPIRATORY DISORDER 161 0.0054
738 DERMATITIS ALLERGIC 67 0.0053
739 CLOSTRIDIUM DIFFICILE INFECTION 116 0.0053
740 DIZZINESS 2635 0.0053
741 COLITIS 200 0.0053
742 FEEDING DISORDER 107 0.0053
743 GASTRIC ULCER 100 0.0053
744 LUNG NEOPLASM MALIGNANT 215 0.0052
745 NAUSEA 4140 0.0052
746 ANGINA PECTORIS 149 0.0052
747 CONTRAINDICATED PRODUCT ADMINISTERED 157 0.0052
748 LYMPHADENOPATHY 183 0.0052
749 HEART RATE DECREASED 181 0.0051
750 SENSORY DISTURBANCE 82 0.0051
751 HAEMATOMA 132 0.0051
752 PULMONARY HYPERTENSION 106 0.0051
753 ANOSMIA 73 0.0050
754 INTERNATIONAL NORMALISED RATIO INCREASED 143 0.0050
755 OSTEOPENIA 76 0.0050
756 UPPER RESPIRATORY TRACT INFECTION 231 0.0050
757 GLAUCOMA 96 0.0050
758 LYMPHOMA 77 0.0050
759 MYOCARDIAL INFARCTION 869 0.0050
760 HAEMORRHOIDS 97 0.0050
761 MALAISE 2178 0.0050
762 TUBULOINTERSTITIAL NEPHRITIS 93 0.0050
763 HEMIPARESIS 84 0.0050
764 VERTIGO 300 0.0049
765 EPISTAXIS 368 0.0049
766 HAEMATURIA 168 0.0049
767 IRRITABLE BOWEL SYNDROME 105 0.0049
768 GALLBLADDER DISORDER 87 0.0049
769 PRODUCT PRESCRIBING ISSUE 105 0.0048
770 ABDOMINAL DISTENSION 497 0.0048
771 HAEMORRHAGE INTRACRANIAL 71 0.0047
772 VISUAL IMPAIRMENT 587 0.0047
773 EMOTIONAL DISTRESS 573 0.0047
774 EAR PAIN 92 0.0047
775 FATIGUE 3681 0.0047
776 BLOOD TEST ABNORMAL 66 0.0047
777 UPPER GASTROINTESTINAL HAEMORRHAGE 79 0.0047
778 THERAPY CESSATION 241 0.0047
779 MUSCULAR WEAKNESS 533 0.0047
780 RESPIRATORY TRACT INFECTION 122 0.0047
781 PRESCRIBED UNDERDOSE 93 0.0047
782 HYPERTHYROIDISM 67 0.0046
783 SYSTEMIC LUPUS ERYTHEMATOSUS 164 0.0046
784 SUBDURAL HAEMATOMA 66 0.0046
785 THYROID DISORDER 71 0.0046
786 HAEMOPTYSIS 128 0.0046
787 BONE MARROW FAILURE 93 0.0046
788 MENORRHAGIA 89 0.0045
789 POST PROCEDURAL COMPLICATION 87 0.0045
790 TOOTHACHE 82 0.0045
791 MASS 63 0.0045
792 MIDDLE INSOMNIA 84 0.0045
793 ABASIA 111 0.0045
794 CEREBROVASCULAR ACCIDENT 755 0.0045
795 BLOOD PRESSURE INCREASED 680 0.0044
796 FLUID RETENTION 225 0.0044
797 BRONCHITIS 327 0.0044
798 ABSCESS 70 0.0044
799 CEREBRAL HAEMORRHAGE 157 0.0044
800 DRUG DISPENSING ERROR 67 0.0044
801 BLOOD PRESSURE ABNORMAL 87 0.0044
802 CARDIAC FAILURE CONGESTIVE 351 0.0044
803 MENSTRUATION IRREGULAR 117 0.0044
804 PRODUCT SUBSTITUTION ISSUE 251 0.0044
805 CARDIOVASCULAR DISORDER 109 0.0043
806 ATRIAL FIBRILLATION 417 0.0043
807 ANKLE FRACTURE 66 0.0043
808 JOINT INJURY 91 0.0043
809 HIP FRACTURE 137 0.0043
810 WHEEZING 252 0.0042
811 ANGIOEDEMA 187 0.0042
812 PNEUMOTHORAX 67 0.0042
813 HYPOAESTHESIA 629 0.0042
814 DYSPNOEA 2373 0.0042
815 FULL BLOOD COUNT DECREASED 84 0.0042
816 BACTERIAL INFECTION 77 0.0041
817 PREGNANCY 82 0.0041
818 ULCER 65 0.0041
819 RENAL INJURY 121 0.0041
820 INTERVERTEBRAL DISC PROTRUSION 89 0.0041
821 FRACTURE 77 0.0041
822 MUSCLE SPASMS 744 0.0041
823 PROTEINURIA 77 0.0040
824 EYE DISORDER 132 0.0040
825 NEURALGIA 97 0.0040
826 CONTUSION 384 0.0040
827 DISCOMFORT 243 0.0040
828 SWELLING FACE 259 0.0040
829 SKIN LESION 109 0.0040
830 DIARRHOEA 2563 0.0040
831 GAIT INABILITY 132 0.0039
832 GASTROINTESTINAL DISORDER 353 0.0039
833 CHRONIC KIDNEY DISEASE 298 0.0039
834 NECK PAIN 218 0.0039
835 GASTROINTESTINAL HAEMORRHAGE 326 0.0039
836 LABORATORY TEST ABNORMAL 115 0.0039
837 OSTEOPOROSIS 160 0.0039
838 BACK DISORDER 63 0.0039
839 MOBILITY DECREASED 278 0.0039
840 CHILLS 453 0.0039
841 JOINT STIFFNESS 101 0.0038
842 NIGHT SWEATS 124 0.0038
843 DYSPEPSIA 377 0.0038
844 INFECTION 554 0.0038
845 FIBROMYALGIA 93 0.0038
846 TOOTH DISORDER 85 0.0038
847 LIP SWELLING 127 0.0038
848 TOOTH LOSS 79 0.0038
849 DISEASE PROGRESSION 446 0.0038
850 BACK PAIN 861 0.0037
851 LUNG DISORDER 181 0.0037
852 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0037
853 END STAGE RENAL DISEASE 67 0.0037
854 PRODUCTIVE COUGH 175 0.0037
855 OROPHARYNGEAL PAIN 339 0.0037
856 ABDOMINAL PAIN UPPER 751 0.0036
857 OSTEOMYELITIS 66 0.0036
858 SINUS DISORDER 72 0.0036
859 PRODUCT USE ISSUE 682 0.0036
860 ILL-DEFINED DISORDER 220 0.0036
861 MYALGIA 614 0.0036
862 RASH GENERALISED 93 0.0036
863 FOOT FRACTURE 68 0.0036
864 MIGRAINE 342 0.0036
865 VIRAL INFECTION 119 0.0036
866 UNDERDOSE 259 0.0035
867 SPINAL FRACTURE 71 0.0035
868 THROMBOSIS 285 0.0035
869 PERIPHERAL SWELLING 543 0.0035
870 PARAESTHESIA 548 0.0035
871 LOCALISED INFECTION 84 0.0035
872 MELAENA 76 0.0034
873 STOMATITIS 208 0.0034
874 HYPOACUSIS 146 0.0034
875 CYSTITIS 107 0.0034
876 OSTEOARTHRITIS 141 0.0033
877 ABORTION SPONTANEOUS 132 0.0033
878 ADVERSE EVENT 303 0.0033
879 INTENTIONAL PRODUCT USE ISSUE 286 0.0033
880 UPPER LIMB FRACTURE 65 0.0033
881 HAEMATOCHEZIA 180 0.0033
882 DEATH 2789 0.0032
883 HEADACHE 2026 0.0032
884 THROAT TIGHTNESS 87 0.0032
885 CHEST DISCOMFORT 329 0.0032
886 INFLUENZA LIKE ILLNESS 264 0.0032
887 LIMB INJURY 87 0.0032
888 PAIN IN JAW 90 0.0032
889 IMPAIRED HEALING 104 0.0032
890 DYSPHONIA 184 0.0031
891 PAIN IN EXTREMITY 924 0.0031
892 FLATULENCE 177 0.0031
893 INTERSTITIAL LUNG DISEASE 151 0.0031
894 RHINORRHOEA 201 0.0031
895 SKIN ULCER 80 0.0031
896 ALOPECIA 603 0.0031
897 LIMB DISCOMFORT 95 0.0031
898 DRUG EFFECT INCOMPLETE 111 0.0031
899 NASAL CONGESTION 178 0.0030
900 DRUG EFFECT DECREASED 163 0.0030
901 BLOOD GLUCOSE DECREASED 145 0.0030
902 SWELLING 281 0.0030
903 ORAL PAIN 67 0.0030
904 RASH 1297 0.0030
905 AGEUSIA 74 0.0030
906 MALIGNANT NEOPLASM PROGRESSION 301 0.0029
907 SKIN DISORDER 98 0.0029
908 DRY EYE 146 0.0029
909 ABDOMINAL DISCOMFORT 487 0.0029
910 PAIN OF SKIN 78 0.0029
911 INFLAMMATION 149 0.0029
912 EYE PAIN 162 0.0029
913 DRUG DEPENDENCE 460 0.0029
914 THERAPEUTIC RESPONSE UNEXPECTED 128 0.0029
915 RASH ERYTHEMATOUS 136 0.0028
916 MUSCULOSKELETAL PAIN 148 0.0028
917 PAIN 1725 0.0028
918 CATARACT 167 0.0028
919 BURNING SENSATION 196 0.0028
920 CHROMATURIA 63 0.0028
921 NEPHROLITHIASIS 128 0.0028
922 WRONG TECHNIQUE IN DRUG USAGE PROCESS 101 0.0028
923 SKIN DISCOLOURATION 127 0.0028
924 UNEVALUABLE EVENT 209 0.0028
925 EYE SWELLING 102 0.0027
926 COUGH 768 0.0027
927 GASTRIC DISORDER 93 0.0027
928 COVID-19 474 0.0027
929 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 187 0.0026
930 DYSPNOEA EXERTIONAL 99 0.0026
931 DRUG ADMINISTRATION ERROR 80 0.0026
932 DYSGEUSIA 193 0.0026
933 INFLUENZA 288 0.0026
934 JOINT SWELLING 311 0.0026
935 DEAFNESS 67 0.0026
936 RASH PRURITIC 138 0.0025
937 FEELING HOT 156 0.0025
938 ABDOMINAL PAIN LOWER 64 0.0025
939 NEOPLASM PROGRESSION 88 0.0025
940 INTENTIONAL DOSE OMISSION 72 0.0025
941 THERAPY INTERRUPTED 180 0.0025
942 THERAPEUTIC PRODUCT EFFECT DECREASED 112 0.0025
943 EYE PRURITUS 84 0.0025
944 ASTHMA 282 0.0025
945 DIVERTICULITIS 69 0.0025
946 EAR INFECTION 66 0.0025
947 MYELOSUPPRESSION 88 0.0024
948 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440 0.0024
949 HAEMORRHAGE 253 0.0024
950 BLISTER 134 0.0024
951 FEMUR FRACTURE 73 0.0024
952 ECZEMA 122 0.0023
953 HYPERSENSITIVITY 431 0.0023
954 VAGINAL HAEMORRHAGE 97 0.0022
955 OCULAR HYPERAEMIA 103 0.0022
956 SINUSITIS 220 0.0021
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 434 0.0021
958 ARTHRALGIA 880 0.0021
959 BONE PAIN 123 0.0021
960 INCORRECT ROUTE OF DRUG ADMINISTRATION 73 0.0020
961 ILLNESS 210 0.0020
962 ERYTHEMA 419 0.0020
963 DRY SKIN 269 0.0020
964 ARTHRITIS 156 0.0020
965 NASOPHARYNGITIS 364 0.0020
966 ANAPHYLACTIC REACTION 109 0.0020
967 FUNGAL INFECTION 65 0.0019
968 INCORRECT DOSE ADMINISTERED 445 0.0019
969 MULTIPLE SCLEROSIS 91 0.0019
970 HOT FLUSH 141 0.0019
971 DRUG DOSE OMISSION 309 0.0019
972 PRURITUS 703 0.0018
973 FLUSHING 184 0.0018
974 PRODUCT DOSE OMISSION ISSUE 530 0.0018
975 COLITIS ULCERATIVE 80 0.0018
976 SURGERY 103 0.0018
977 NEOPLASM MALIGNANT 117 0.0018
978 HERPES ZOSTER 99 0.0017
979 DEPENDENCE 90 0.0016
980 ARTHROPATHY 91 0.0016
981 INFUSION RELATED REACTION 107 0.0016
982 ACNE 122 0.0016
983 URTICARIA 255 0.0015
984 EYE IRRITATION 83 0.0014
985 PRODUCT DOSE OMISSION 94 0.0014
986 SKIN EXFOLIATION 114 0.0013
987 BREAST CANCER 113 0.0012
988 MULTIPLE SCLEROSIS RELAPSE 79 0.0012
989 PSORIASIS 146 0.0011
990 PRODUCT QUALITY ISSUE 141 0.0010
991 RHEUMATOID ARTHRITIS 88 0.0008
992 NO ADVERSE EVENT 135 0.0007
993 ACCIDENTAL EXPOSURE TO PRODUCT 73 0.0007
994 INJECTION SITE PAIN 180 0.0006